Stephen A Sherwin
Director at Neurocrine Biosciences Inc (NBIX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 9SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 7,88332,977 held (−19%) | $163.81 | $1.3M | -13.0% |
| Jun 9SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 2,54930,428 held (−8%) | $164.44 | $419K | -13.4% |
| Jun 9SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 6,89623,532 held (−23%) | $165.79 | $1.1M | -14.1% |
| Jun 9SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 5,82917,703 held (−25%) | $166.56 | $971K | -14.5% |
| Jun 9SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 1,84315,860 held (−10%) | $167.31 | $308K | -14.9% |
- Sell
Director Stephen A Sherwin sold $1.3M of NBIX at $163.81 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Stephen A Sherwin sold $419K of NBIX at $164.44 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Stephen A Sherwin sold $1.1M of NBIX at $165.79 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Stephen A Sherwin sold $971K of NBIX at $166.56 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Stephen A Sherwin sold $308K of NBIX at $167.31 — pre-scheduled 10b5-1 plan sale.